A long-held assumption about amoebae is being challenged

Amoebae are single-celled organisms found in freshwater, saltwater and moist environments. Several species can cause serious infections, and researchers have long considered their size a major obstacle for the human immune system: they were thought to be too large for immune cells to swallow.

New work from the University of Louisville challenges that view. The researchers report that human macrophages and neutrophils can efficiently engulf two amoeba species, Acanthamoeba polyphaga and Vermamoeba vermiformis. The study was published in the peer-reviewed journal mBio.

The finding does not mean every disease-causing amoeba is handled in the same way, or that existing treatments can be replaced. But it revises a basic question in host defense: whether phagocytosis, one of the immune system’s core mechanisms for removing microbes, can act directly on organisms of this scale.

How phagocytosis fits into the result

Phagocytosis is the process by which certain immune cells surround, ingest and destroy invading material. Macrophages and neutrophils are among the best-known phagocytic cells. They are important parts of the body’s early response to infection, helping identify and remove threats before an infection becomes more established.

In this study, researchers found that both cell types could engulf the two tested amoebae. That observation matters because amoebae are relatively large compared with many bacteria and other microbes commonly discussed in connection with phagocytosis. The work therefore suggests that cell size alone does not set as firm a limit on this immune defense as previously assumed.

Lead author Yousef Abu Kwaik, a professor in the University of Louisville School of Medicine’s Department of Microbiology and Immunology, said the results challenge the belief that human macrophages and neutrophils cannot swallow amoebae. The study frames the result as a change in how researchers understand immune defenses against large microbes.

One amoeba appears to use a different strategy

The research also points to an important limitation. A third species examined by the team, Entamoeba histolytica, appeared able to avoid the same fate when alive. According to the researchers, it briefly contacted immune cells and then escaped, a behavior they describe as “kiss and run.”

New UofL study reveals immune cells' ability to engulf and destroy amoebae
Scanning electron microscopy images show human macrophages (red, Mφ) with live (left) or killed (right) amoeba, E. histolytica (blue, Eh). Green arrows in the left image show fiber membrane formed by the macrophages around the live E. histolytica. On the right, white arrows indicate close contact between the macrophage membranes and killed Eh that leads to engulfing of the killed amoeba. Credit: University of Louisville

That contrast is significant. It suggests that interactions between amoebae and immune cells may depend not only on the relative sizes of the organisms, but also on the particular biology and behavior of each species. In other words, showing that immune cells can engulf some amoebae does not establish a universal response across amoebic infections.

The researchers did find that macrophages could engulf dead E. histolytica cells. That difference between live and killed cells further indicates that the living amoeba’s ability to evade contact may be central to its defense. Understanding the mechanisms behind that escape could be as important as understanding the engulfment observed in the other species.

Why the finding matters

The report places the research in the context of a substantial health burden. More than 100 million severe infections are believed to be caused worldwide each year by different amoeba species. Antibiotics are often effective for these infections, but the new findings focus on a separate issue: what the body’s own immune cells may be able to do before, alongside or after medical treatment.

That distinction is essential. The study does not establish a new clinical treatment, and it does not claim that immune cells will reliably clear amoebic infection in patients. Rather, it provides evidence that two major immune-cell types have a capacity that had been discounted. Such basic findings can change the questions researchers ask about disease progression, susceptibility and possible therapeutic strategies.

For example, future work may examine what allows macrophages and neutrophils to surround these particular amoebae, whether the response varies among people, and how the “kiss and run” behavior of E. histolytica works at a molecular level. The current report supports those questions, but does not answer them.

A narrower result with broader implications

Research advances often begin by replacing a broad assumption with a more precise one. In this case, the old assumption was that amoebae are simply too large for human phagocytic cells to ingest. The new evidence supports a narrower conclusion: at least two amoeba species can be efficiently engulfed by human macrophages and neutrophils under the conditions studied.

That leaves substantial work ahead, including determining how this mechanism operates during real infections and why it fails against some organisms. Still, the finding gives immunologists a clearer starting point. Large single-celled pathogens are not necessarily beyond the reach of the immune system’s cellular cleanup machinery.

  • Macrophages and neutrophils engulfed Acanthamoeba polyphaga and Vermamoeba vermiformis.
  • Live Entamoeba histolytica appeared to evade immune cells through brief contact followed by escape.
  • The study changes a long-standing assumption but does not establish a new treatment.

This article is based on reporting by Phys.org. Read the original article.

Originally published on phys.org